An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive digestive malignancy due to frequent late-stage diagnosis, rapid progression and resistance to therapy. With increasing PDAC incidence worldwide, there is an urgent need for new prognostic biomarkers and therapy targets. Recently, RNA me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Duo, Yang, Zhirong, Zhang, Shuman, Yang, Hai, Liu, Dongxue, Grützmann, Robert, Pilarsky, Christian, Britzen-Laurent, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437259/
https://www.ncbi.nlm.nih.gov/pubmed/36060802
http://dx.doi.org/10.3389/fcell.2022.975684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437259/
https://www.ncbi.nlm.nih.gov/pubmed/36060802
http://dx.doi.org/10.3389/fcell.2022.975684

Ejemplares similares